Photofrin® photodynamic therapy: 2.0 mg/kg or not 2.0 mg/kg that is the question

Photodiagnosis and Photodynamic Therapy

Volumn 5, Issue 2, 2008, Pages 112-119

  Allison, Ron R ^a   Sibata, Claudio H ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Dosimetry; Low dose; Photofrin ; Photosensitizer concentration

Indexed keywords

PHOTOFRIN; PHOTOFRIN II; PHOTOSENSITIZING AGENT;

ARTICLE; BREAST CANCER; DISEASE CONTROL; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MEGADOSE; ESOPHAGUS INJURY; HEAD AND NECK CANCER; HUMAN; LIGHT INTENSITY; LOW DRUG DOSE; LUNG LESION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR LOCALIZATION; NEOPLASM; PHOTOCHEMOTHERAPY; RADIATION RESPONSE;

DIHEMATOPORPHYRIN ETHER; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

EID: 46749139401     PISSN: 15721000     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2008.05.004     Document Type: Article

References (57)

1. Allison R.R., Mota H.C., and Sibata C.H. Clinical PD/PDT in North America: an historical review. Photodiag Photodyn Ther 1 4 (2004) 263-277
2. Chopra R., Kondziolka D., Niranjan A., et al. Long-term follow-up of acoustic schwannoma radiosurgery with marginal tumor doses of 12 to 13 Gy. Int J Radiat Oncol Biol Phys 68 3 (2007) 845-851
3. Martin J.J., Niranjan A., Kondziolka D., et al. Radiosurgery for chordomas and chondrosarcomas of the skull base. J Neurosurg 107 4 (2007) 758-764
4. Mathieu D., Kondziolka D., Flickinger J.C., et al. Stereotactic radiosurgery for vestibular schwannomas in patients with neurofibromatosis type 2: an analysis of tumor control, complications, and hearing preservation rates. Neurosurgery 60 3 (2007) 460-468 [discussion 468-470]
5. Perez C.A., Brady L.W., and Halperin E.C. Perez and Brady's principles and practice of radiation oncology. 5th ed. (2008), Lippincott Williams & Wilkins, Philadelphia
6. Zelefsky M.J., Levin E.J., Hunt M., et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 70 4 (2008) 1124-1129
7. Wilson B.C., Patterson M.S., and Lilge L. Implicit and explicit dosimetry in photodynamic therapy: a new paradigm. Lasers Med Sci 12 (1997) 182-199
8. Patterson M.S., and Wilson B.C. Photodynamic therapy. In: Dyh J.V. (Ed). The modern technology of radiation oncology (1999), Medical Physics Publishing, Madison 941-980
9. Dougherty T.J. Photodynamic therapy. Photochem Photobiol 58 6 (1993) 895-900
10. Mang T. Lasers and light sources for PDT: past, present and future. Photodiag Photodyn Ther 1 1 (2004) 43-48
11. Henderson B.W., and Dougherty T.J. How does photodynamic therapy work?. Photochem Photobiol 55 1 (1992) 145-157
12. Allison R.R., Downie G.H., Cuenca R., et al. Photosensitizers in clinical PDT. Photodiag Photodyn Ther 1 1 (2004) 27-42
13. Sibata C.H., Colussi V.C., Oleinick N.L., et al. Photodynamic therapy: a new concept in medical treatment. Braz J Med Biol Res 33 8 (2000) 869-880
14. Dougherty T.J., Gomer C.J., Henderson B.W., et al. Photodynamic therapy. J Natl Cancer Inst 90 12 (1998) 889-905
15. Kessel D., Thompson P., Musselman B., et al. Probing the structure and stability of the tumor-localizing derivative of hematoporphyrin by reductive cleavage with LiAlH4. Cancer Res 47 17 (1987) 4642-4645
16. Rosenkranz A.A., Jans D.A., and Sobolev A.S. Targeted intracellular delivery of photosensitizers to enhance photodynamic efficiency. Immunol Cell Biol 78 4 (2000) 452-464
17. Fingar V.H., Potter W.R., and Henderson B.W. Drug and light dose dependence of photodynamic therapy: a study of tumor cell clonogenicity and histologic changes. Photochem Photobiol 45 5 (1987) 643-650
18. Mang T.S., Dougherty T.J., Potter W.R., et al. Photobleaching of porphyrins used in photodynamic therapy and implications for therapy. Photochem Photobiol 45 4 (1987) 501-506
19. Dougherty T.J. Photodynamic therapy: Part II. Semin Surg Oncol 11 5 (1995) 333-334
20. Kato H. Photodynamic therapy for early stage central type of lung cancer. Mayo Clin Proc 72 7 (1997) 688-690
21. Cortese D.A., Edell E.S., and Kinsey J.H. Photodynamic therapy for early stage squamous cell carcinoma of the lung. Mayo Clin Proc 72 7 (1997) 595-602
22. Grosjean P., Wagnieres G., Fontolliet C., et al. Clinical photodynamic therapy for superficial cancer in the oesophagus and the bronchi: 514 nm compared with 630 nm light irradiation after sensitization with Photofrin II. Br J Cancer 77 11 (1998) 1989-1995
23. Overholt B.F. Evaluating treatments of Barrett's esophagus that shows high-grade dysplasia. Am J Manag Care 6 16 Suppl. (2000) S903-S908
24. Moghissi K., and Dixon K. Is bronchoscopic photodynamic therapy a therapeutic option in lung cancer?. Eur Respir J 22 3 (2003) 535-541
25. Lightdale C.J. Role of photodynamic therapy in the management of advanced esophageal cancer. Gastrointest Endosc Clin N Am 10 3 (2000) 397-408
26. Jones C.M., Mang T., Cooper M., et al. Photodynamic therapy in the treatment of Bowen's disease. J Am Acad Dermatol 27 6 Pt 1 (1992) 979-982
27. Runfola M.A., Weber T.K., Rodriguez-Bigas M.A., et al. Photodynamic therapy for residual neoplasms of the perianal skin. Dis Colon Rectum 43 4 (2000) 499-502
28. Taber S.W., Fingar V.H., and Wieman T.J. Photodynamic therapy for palliation of chest wall recurrence in patients with breast cancer. J Surg Oncol 68 4 (1998) 209-214
29. Schuh M., Nseyo U.O., Potter W.R., et al. Photodynamic therapy for palliation of locally recurrent breast carcinoma. J Clin Oncol 5 11 (1987) 1766-1770
30. Khan S.A., Dougherty T.J., and Mang T.S. An evaluation of photodynamic therapy in the management of cutaneous metastases of breast cancer. Eur J Cancer 29A 12 (1993) 1686-1690
31. Biel M.A. Photodynamic therapy in head and neck cancer. Curr Oncol Rep 4 1 (2002) 87-96
32. Nseyo U.O., and Lamm D.L. Therapy of superficial bladder cancer. Semin Oncol 23 5 (1996) 598-604
33. Moghissi K., Dixon K., Stringer M., et al. The place of bronchoscopic photodynamic therapy in advanced unresectable lung cancer: experience of 100 cases. Eur J Cardiothorac Surg 15 1 (1999) 1-6
34. Edell E.S., Cortese D.A., and McDougall J.C. Ancillary therapies in the management of lung cancer: photodynamic therapy, laser therapy, and endobronchial prosthetic devices. Mayo Clin Proc 68 7 (1993) 685-690
35. Wolfsen H.C. Photodynamic therapy in gastroenterology: current status in the year 2000. Endoscopy 32 9 (2000) 715-719
36. Allison R.R., Cuenca R., Downie G.H., et al. Clinical photodynamic therapy of head and neck cancers-a review of applications and outcomes. Photodiag Photodyn Ther 2 3 (2005) 205-222
37. Allison R.R., Sibata C.H., Downie G.H., et al. A clinical review of PDT for cutaneous malignancies. Photodiag Photodyn Ther 3 4 (2006) 214-226
38. Khan S.A.D.T., and Mang T.S. An evaluation of photodynamic therapy in the management of cutaneous metastases of breast cancer. Br J Cancer 29A (1993) 1686-1690
39. Nseyo U.O., Shumaker B., Klein E.A., et al. Photodynamic therapy using porfimer sodium as an alternative to cystectomy in patients with refractory transitional cell carcinoma in situ of the bladder. Bladder Photofrin Study Group. J Urol 160 1 (1998) 39-44
40. Kriegmair M., Waidelich R., Lumper W., et al. Integral photodynamic treatment of refractory superficial bladder cancer. J Urol 154 4 (1995) 1339-1341
41. Wilson B.D., Mang T.S., Stoll H., et al. Photodynamic therapy for the treatment of basal cell carcinoma. Arch Dermatol 128 12 (1992) 1597-1601
42. McCaughan Jr. J.S., Guy J.T., Hawley P., et al. Hematoporphyrin-derivative and photoradiation therapy of malignant tumors. Lasers Surg Med 3 3 (1983) 199-209
43. Baert L., Berg R., Van Damme B., et al. Clinical fluorescence diagnosis of human bladder carcinoma following low-dose Photofrin injection. Urology 41 4 (1993) 322-330
44. Allison R.R., Mota H.C., Bagnato V.S., et al. Bio-nanotechnology and photodynamic therapy-state of art review. Photodiag Photodyn Ther 5 (2008) 19-28
45. Oseroff A.R., Blumenson L.R., Wilson B.D., et al. A dose ranging study of photodynamic therapy with porfimer sodium (Photofrin) for treatment of basal cell carcinoma. Lasers Surg Med 38 5 (2006) 417-426
46. Henderson B.W., Busch T.M., Vaughan L.A., et al. Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate. Cancer Res 60 3 (2000) 525-529
47. Fingar V.H., and Henderson B.W. Drug and light dose dependence of photodynamic therapy: a study of tumor and normal tissue response. Photochem Photobiol 46 5 (1987) 837-841
48. Buchanan R.B., Carruth J.A., McKenzie A.L., et al. Photodynamic therapy in the treatment of malignant tumours of the skin and head and neck. Eur J Surg Oncol 15 5 (1989) 400-406
49. Robinson P.J., Carruth J.A., and Fairris G.M. Photodynamic therapy: a better treatment for widespread Bowen's disease. Br J Dermatol 119 1 (1988) 59-61
50. Wilson B.D., Mang T.S., Cooper M., et al. Use of photodynamic therapy for the treatment of extensive basal cell carcinomas. Facial Plast Surg 6 3 (1989) 185-189
51. Zeitouni N.C., Oseroff A.R., and Shieh S. Photodynamic therapy for nonmelanoma skin cancers. Current review and update. Mol Immunol 39 17-18 (2003) 1133-1136
52. Oseroff A. PDT as a cytotoxic agent and biological response modifier: implications for cancer prevention and treatment in immunosuppressed and immunocompetent patients. J Invest Dermatol 126 3 (2006) 542-544
53. Allison R.R., Mang T.S., and Wilson B.D. Photodynamic therapy for the treatment of nonmelanomatous cutaneous malignancies. Semin Cutan Med Surg 17 2 (1998) 153-163
54. Allison R., Mang T., Hewson G., et al. Photodynamic therapy for chest wall progression from breast carcinoma is an underutilized treatment modality. Cancer 91 1 (2001) 1-8
55. Cuenca R.E., Allison R.R., Sibata C., et al. Breast cancer with chest wall progression: treatment with photodynamic therapy. Ann Surg Oncol 11 3 (2004) 322-327
56. Sperduto P.W., DeLaney T.F., Thomas G., et al. Photodynamic therapy for chest wall recurrence in breast cancer. Int J Radiat Oncol Biol Phys 21 2 (1991) 441-446
57. Bernstein Z.P., Wilson B.D., Oseroff A.R., et al. Photofrin photodynamic therapy for treatment of AIDS-related cutaneous Kaposi's sarcoma. AIDS 13 13 (1999) 1697-1704